147 related articles for article (PubMed ID: 36174950)
1. Discovery and validation of bladder cancer related excreted nucleosides biomarkers by dilution approach in cell culture supernatant and urine using UHPLC-MS/MS.
Chang Q; Chen P; Yin J; Liang G; Dai Y; Guan Y; Chen Y; Zhao Y; Lu YJ; Zhang L; Song D; Yuan H
J Proteomics; 2023 Jan; 270():104737. PubMed ID: 36174950
[TBL] [Abstract][Full Text] [Related]
2. Using UHPLC Q-Trap/MS as a complementary technique to in-depth mine UPLC Q-TOF/MS data for identifying modified nucleosides in urine.
Lu Z; Wang Q; Wang M; Fu S; Zhang Q; Zhang Z; Zhao H; Liu Y; Huang Z; Xie Z; Yu H; Gao X
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():108-117. PubMed ID: 28340480
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a rapid LC-MS/MS method for determination of methylated nucleosides and nucleobases in urine.
Raćkowska E; Bobrowska-Korczak B; Giebułtowicz J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1128():121775. PubMed ID: 31493699
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
Godoy AT; Eberlin MN; Simionato AVC
Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
[TBL] [Abstract][Full Text] [Related]
5. Exploring urinary modified nucleosides as biomarkers for diabetic retinopathy: Development and validation of a ultra performance liquid chromatography-tandem mass spectrometry method.
Yao C; Lv D; Zhou X; Fu P; Sun W; Chen J; Lin H
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123968. PubMed ID: 38150972
[TBL] [Abstract][Full Text] [Related]
6. BH
Lu Z; Liu X; Li X; Zhai C; Shi Y; Gao X
J Pharm Biomed Anal; 2022 Feb; 210():114555. PubMed ID: 34974239
[TBL] [Abstract][Full Text] [Related]
7. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.
Rodríguez-Gonzalo E; Herrero-Herrero L; García-Gómez D
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():132-9. PubMed ID: 26565068
[TBL] [Abstract][Full Text] [Related]
8. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
Mao Y; Zhao X; Wang S; Cheng Y
Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
[TBL] [Abstract][Full Text] [Related]
9. Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
Chen YT; Huang HC; Hsieh YJ; Fu SH; Li L; Chen CL; Chu LJ; Yu JS
J Food Drug Anal; 2019 Apr; 27(2):460-474. PubMed ID: 30987717
[TBL] [Abstract][Full Text] [Related]
10. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK
Tumori; 2014; 100(6):660-6. PubMed ID: 25688500
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins.
Guo J; Ren Y; Hou G; Wen B; Xian F; Chen Z; Cui P; Xie Y; Zi J; Lin L; Wu S; Li Z; Wu L; Lou X; Liu S
J Proteome Res; 2016 Jul; 15(7):2164-77. PubMed ID: 27265680
[TBL] [Abstract][Full Text] [Related]
12. A simultaneously quantitative method to profiling twenty endogenous nucleosides and nucleotides in cancer cells using UHPLC-MS/MS.
Zhu B; Wei H; Wang Q; Li F; Dai J; Yan C; Cheng Y
Talanta; 2018 Mar; 179():615-623. PubMed ID: 29310284
[TBL] [Abstract][Full Text] [Related]
13. Targeted quantitative metabolomics with a linear mixed-effect model for analysis of urinary nucleosides and deoxynucleosides from bladder cancer patients before and after tumor resection.
Artymowicz M; Struck-Lewicka W; Wiczling P; Markuszewski M; Markuszewski MJ; Siluk D
Anal Bioanal Chem; 2023 Sep; 415(22):5511-5528. PubMed ID: 37460824
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
[TBL] [Abstract][Full Text] [Related]
15. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
[TBL] [Abstract][Full Text] [Related]
16. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to measure creatinine in human urine.
Fraselle S; De Cremer K; Coucke W; Glorieux G; Vanmassenhove J; Schepers E; Neirynck N; Van Overmeire I; Van Loco J; Van Biesen W; Vanholder R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():88-97. PubMed ID: 25756209
[TBL] [Abstract][Full Text] [Related]
18. Untargeted metabolomics of bladder tissue using liquid chromatography and quadrupole time-of-flight mass spectrometry for cancer biomarker detection.
Nizioł J; Ossoliński K; Płaza-Altamer A; Kołodziej A; Ossolińska A; Ossoliński T; Krupa Z; Ruman T
J Pharm Biomed Anal; 2024 Mar; 240():115966. PubMed ID: 38217999
[TBL] [Abstract][Full Text] [Related]
19. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
